Your browser doesn't support javascript.
loading
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
Del Re, Marzia; Petrini, Iacopo; Mazzoni, Francesca; Valleggi, Simona; Gianfilippo, Giulia; Pozzessere, Daniele; Chella, Antonio; Crucitta, Stefania; Rofi, Eleonora; Restante, Giuliana; Miccoli, Mario; Garassino, Marina Chiara; Danesi, Romano.
Affiliation
  • Del Re M; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Petrini I; Unit of Pneumology, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Mazzoni F; Unit of Medical Oncology, Department of Oncology, University Hospital of Firenze, Firenze, Italy.
  • Valleggi S; Unit of Pneumology, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Gianfilippo G; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Pozzessere D; Unit of Medical Oncology, Department of Oncology, Hospital of Prato, Prato, Italy.
  • Chella A; Unit of Pneumology, Azienda Ospedaliero-Universitaria Pisana and Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Crucitta S; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Rofi E; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Restante G; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Miccoli M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Garassino MC; Thoraco-pulmonary Medical Oncology Unit, Medical Oncology and Hematology Department, National Tumor Institute, IRCCS, Milan, Italy.
  • Danesi R; Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Electronic address: romano.danesi@unipi.it.
Clin Lung Cancer ; 21(3): 232-237, 2020 05.
Article in En | MEDLINE | ID: mdl-31735523
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Cell-Free Nucleic Acids / Lung Neoplasms / Mutation Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Cell-Free Nucleic Acids / Lung Neoplasms / Mutation Type of study: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Country of publication: